CRWVCoreWeave, Inc.

$82.29-34% 1Y

Is the business good?

Mixed

5 of 9 health tests passed. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 neutral, 3 without data
Fundamental health (F-score)5 / 9SEC EDGAR · Dec 31, 2025

Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Leverage (Debt/EBITDA)bottom 7% of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is CRWV?

CoreWeave, Inc. earns −0.52% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.

−0.52%

Return on invested capital · cost of capital 9.0% · 9.5 points below what the capital costs: growth destroys value

Operating margin
−3.0%

Operating margin · Software - Infrastructure median 5.8% · 12 months to Q2 2026

Share count, year on year
+13%

Share count, year on year · shareholders own a smaller slice than a year ago

R&D as % of revenue
5.6%

R&D as % of revenue

Operating margin by fiscal year
YearOperating margin
FY2023−6.1%
FY202417%
FY2025−0.90%
Details›
Gross margin12 months to Q2 2026
67%
Operating margin12 months to Q2 2026
−3.0%
Net margin12 months to Q2 2026
−25%
Free cash flow margin
−180%
R&D as % of revenue
5.6%
Revenue, trailing twelve months
$7.59B
Free cash flow, trailing twelve months
−$13.7B
Net income, trailing twelve months
−$1.93B
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
−0.52%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.

On our screens:Most shorted stocks